Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.

The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.

Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Osage University Partners.

Stanford-backed expense management platform Jeeves has received series B funding, two months after emerging from stealth.

Ventura Capital has led the round for the Imperial College London-founded rapid covid-19 test kit maker, which will use the funding to expand internationally.

Harvard and MIT-linked Neural Galaxy has picked up $77m in a series A round led by existing shareholder 3E Bioventures.

Vanderbilt University has thrown its weight behind the investment analytics provider as it prepares to expand its offering into new customer segments.

CAS Star-backed MinoSpace has added $46m in pre-series B funding to its coffers.